昆衍生物:具有神经保护潜力的有前途的抗氧化剂
Luis Felipe Hernández-Ayala1, Eduardo Gabriel Guzmán-López1, Annia Galano1
1Departamento de Química, Universidad Autónoma Metropolitana-Iztapalapa, Av. Ferrocarril San Rafael Atlixco 186, Col. Leyes de Reforma 1A Sección, Alcaldía Iztapalapa, México City 09310, Mexico.
Antioxidants (Basel, Switzerland)
|October 28, 2023
概括
研究人员设计了8536种oline衍生物,确定了四种有前途的候选多功能抗氧化剂. 这些化合物显示出治疗神经退行性疾病的潜力,如阿尔茨海默氏症和帕金森症.
科学领域:
- 药用化学 医学化学
- 计算化学计算化学
- 神经科学是一个神经科学.
背景情况:
- 昆衍生物被认为具有多种生物活动.
- 设计新的类化合物对于药物发现至关重要.
- 了解结构-活动关系可以提高治疗潜力.
研究的目的:
- 设计和选用于药物应用的大型林衍生物库.
- 评估精选衍生物的酸,抗氧化和神经保护性质.
- 为了确定神经退行性疾病的新型多功能抗氧化剂.
主要方法:
- 利用CADMA-Chem协议进行8536种氨酸衍生物的战略设计.
- 根据生物可用性,毒性和可制造性,雇员选择和消除得分.
- 预测使用电离潜力和键解离能量的抗氧化活性;通过分子对接评估神经保护.
主要成果:
- 在经过广泛的过后,确定了25种具有有前途性质的氨酸衍生物.
- 抗氧化剂的效率各不相同,一些衍生品的性能优于特罗洛克斯,但不超过 Askorbate.
- 分子对接表明了关键酶 (COMT,ACHE,MAO-B) 的潜在抑制,这些酶与神经退行有关.
结论:
- 四种素衍生物显示出作为多功能抗氧化剂的潜力.
- 这些候选人显示出对抗阿尔茨海默氏症和帕金森病的前景.
- 结构洞察力为进一步优化神经保护剂提供了基础.
相关概念视频
Oxidation of Phenols to Quinones
3.1K
In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
3.1K
Electron Transport Chain: Complex I and II
14.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.2K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
698
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
698
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
131
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
131
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Anticholinesterase Agents: Poisoning and Treatment
889
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
889


